Actively Recruiting

Age: 10Years - 21Years
All Genders
Healthy Volunteers
ID07224113

Assessment and Educational Intervention to Reduce Ultra-Processed Food Consumption in Pediatric Patients With IBD

Led by Connecticut Children's Medical Center · Updated on 2025-11-19

120

Participants Needed

1

Research Sites

12 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating whether simple nutrition education can help children and teens with inflammatory bowel disease (IBD) reduce their intake of ultra-processed foods (UPFs). UPFs include packaged snacks, sugary drinks, and fast food items that are high in added sugars, fats, and artificial ingredients. The study aims to find an effective and practical way to support healthier eating habits and improve long-term gut health in pediatric IBD patients. Participants are divided into three groups: one group receives written nutrition handouts explaining UPFs and how to choose less-processed alternatives; another group receives both the handouts and a short educational video reinforcing key messages about UPFs and healthy eating; and a comparison group of children and teens with disorders of gut-brain interaction completes dietary assessments without receiving educational materials. The interventions are behavioral and delivered as educational tools. During the study, participants will complete online food recalls to measure what they eat. Researchers will compare changes in UPF intake between groups within a 4 to 12 week window after the intervention. Families will also be asked about the usefulness and acceptability of the materials. The study is sponsored by Connecticut Children's Medical Center and involves children and teens aged 10 to under 22 years, with participation lasting several weeks after enrollment.

CONDITIONS

Brief Title

Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD

Who Can Participate

Age: 10Years - 21Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of IBD (Crohn's disease, Ulcerative Colitis, IBD-U) for at least 3 months
  • Age 10 through less than 22 years at enrollment
  • Followed by a gastroenterologist at Connecticut Children's
  • IBD in clinical remission with PUCAI score less than 10 or PCDAI score less than 10
  • Receiving medical infusions at CCMC Infusion Center as part of IBD treatment
  • On full oral intake without major dietary restrictions or need for oral nutrition supplements
Not Eligible

You will not qualify if you...

  • Following a medically prescribed or restrictive diet such as Crohn's Disease Exclusion Diet (CDED), ketogenic diet, Specific Carbohydrate Diet (SCD), low FODMAP diet, gluten-free diet, paleo, or Whole30
  • Receiving nutrition through feeding tubes including nasogastric, nasojejunal, gastrostomy, or gastrojejunostomy tubes
  • History of bowel surgery within 3 months before study start affecting normal enteral intake
  • Non-English-speaking participants due to consent process limitations

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - 4 to 12 weeks

Participants receive educational interventions to reduce ultra-processed food consumption. This includes either written nutrition handouts alone or handouts combined with a short educational video.

1 baseline visit and 1 follow-up visit within 4 to 12 weeks after intervention

Trial Site Locations

Total: 1 location

1

Connecticut Children's Medical Center

Hartford, Connecticut, United States, 06106

Actively Recruiting

Loading map...

Research Team

G

Giselle M Davila Bernardy, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Similar Trials

A Phase 1, First-In-Human Study to Evaluate the Safety, Tole...

Inflammatory Bowel Disease (IBD)

Actively Recruiting

1 location

A Phase 2, Multi-Center, Platform Study to Evaluate the Safe...

Inflammatory Bowel Disease (IBD)

Actively Recruiting

66 locations

A Phase I Clinical Study to Evaluate the Safety, Tolerabilit...

Ulcerative Colitis (UC)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here